75 related articles for article (PubMed ID: 2388394)
1. [Increased fibrinolytic activity during surgery with cardiopulmonary bypass].
Gando S; Tedo I; Goda Y; Kubota M
Masui; 1990 Jun; 39(6):751-6. PubMed ID: 2388394
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
3. Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin.
Kipfer B; Englberger L; Gygax E; Nydegger U; Carrel T
Transfus Apher Sci; 2003 Aug; 29(1):17-24. PubMed ID: 12877888
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
5. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery.
Tanaka K; Takao M; Yada I; Yuasa H; Kusagawa M; Deguchi K
J Cardiothorac Anesth; 1989 Apr; 3(2):181-8. PubMed ID: 2535275
[TBL] [Abstract][Full Text] [Related]
6. [An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].
Gando S; Tedo I
Rinsho Ketsueki; 1990 Nov; 31(11):1774-9. PubMed ID: 2149574
[TBL] [Abstract][Full Text] [Related]
7. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass.
Chandler WL; Fitch JC; Wall MH; Verrier ED; Cochran RP; Soltow LO; Spiess D
Thromb Haemost; 1995 Nov; 74(5):1293-7. PubMed ID: 8607112
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
9. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
[TBL] [Abstract][Full Text] [Related]
11. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
12. [Coagulation and fibrinolysis system in pediatric cardiopulmonary bypass].
Sakamoto T; Asou T; Takeda Y; Date K; Nanaumi M; Nagafuchi H; Koga N; Ohmiya A; Chiba S
Kyobu Geka; 2006 Dec; 59(13):1163-70. PubMed ID: 17163208
[TBL] [Abstract][Full Text] [Related]
13. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
Yoshie M; Hirose Y; Gamo M; Matsuo K
Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
[TBL] [Abstract][Full Text] [Related]
14. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
15. An alternative pathway for fibrinolysis is activated in patients who have undergone cardiopulmonary bypass surgery and major abdominal surgery.
Gando S; Kameue T; Sawamura A; Hayakawa M; Hoshino H; Kubota N
Thromb Res; 2007; 120(1):87-93. PubMed ID: 17023030
[TBL] [Abstract][Full Text] [Related]
16. Effects of nafamostat mesilate on platelets and coagulofibrinolysis during cardiopulmonary bypass surgery.
Tanaka K; Kondo C; Takagi K; Sato T; Yada I; Yuasa H; Kusagawa M
ASAIO J; 1993; 39(3):M545-9. PubMed ID: 8268595
[TBL] [Abstract][Full Text] [Related]
17. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
Eisses MJ; Chandler WL
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
[TBL] [Abstract][Full Text] [Related]
19. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
[TBL] [Abstract][Full Text] [Related]
20. [Increased fibrinolytic activity during cardiopulmonary bypass is caused by activated protein C system].
Gando S; Tedo I; Masio H; Goda Y; Kawahigashi H
Masui; 1994 Jun; 43(6):912-4. PubMed ID: 8072152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
